Maria Getino is a Research Associate in the Priority Pathogens theme at the National Institute of Health Research Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance. The HPRU is a partnership between Imperial College London, UKHSA, Cambridge University, the University of Warwick and Imperial College Health Partners. The Unit was funded, along with 14 others in priority areas from immunisation to radiation hazards, to bring Universities to work in partnership with Public Health England to support excellent health protection research relevant to the needs of Public Health England. It commenced 01 April 2020 for a 5 year period and builds on the legacy of the previous HPRU which ran from 01 April 2014 -31 March 2020.
et al., 2022, Remarkable genomic diversity among Escherichia isolates recovered from healthy chickens, Peerj, Vol:10, ISSN:2167-8359, Pages:1-23
et al., 2021, Conjugation Inhibitors Effectively Prevent Plasmid Transmission in Natural Environments, Mbio, Vol:12, ISSN:2150-7511
et al., 2021, Extensive microbial diversity within the chicken gut microbiome revealed by metagenomics and culture, Peerj, Vol:9, ISSN:2167-8359
et al., 2020, The One Health European Joint Programme (OHEJP), 2018-2022: an exemplary One Health initiative, Journal of Medical Microbiology, Vol:69, ISSN:0022-2615, Pages:1037-1039
et al., 2018, Conjugation inhibitors compete with palmitic acid for binding to the conjugative traffic ATPase TrwD, providing a mechanism to inhibit bacterial conjugation, Journal of Biological Chemistry, Vol:293, Pages:16923-16930